Glucon Preps For 2005 Clinical Trial Of Continuous Blood Sugar Monitor
This article was originally published in The Gray Sheet
Executive Summary
Clinical trials on the sensitivity and specificity of Glucon's continuous glucose monitor will begin in Q3 2005, according to Benny Pesach, PhD, founder and VP-research & development
You may also be interested in...
Abbott/TheraSense FDA panel rescheduled
Diabetes test manufacturer is working with FDA to establish a panel date for the FreeStyle Navigator continuous glucose monitor system, which uses interstitial fluid, after the agency mistakenly issued and then retracted a notice that its Clinical Chemistry & Clinical Toxicology Devices Panel would review the device on Oct. 13. TheraSense submitted a PMA last November. Upon approval, FreeStyle will compete with Medtronic's Guardian CGMS. Roche/Disetronic is developing similar technology...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.